- Home
- GNSS vs CMRX Comparison
GNSS vs CMRX Comparison
Compare GNSS & CMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNSS
- CMRX
- Stock Information
- Founded
- GNSS 1992
- CMRX 2000
- Country
- GNSS United States
- CMRX United States
- Employees
- GNSS N/A
- CMRX N/A
- Industry
- GNSS Consumer Electronics/Appliances
- CMRX Biotechnology: Pharmaceutical Preparations
- Sector
- GNSS Consumer Staples
- CMRX Health Care
- Exchange
- GNSS Nasdaq
- CMRX Nasdaq
- Market Cap
- GNSS 169.5M
- CMRX 77.0M
- IPO Year
- GNSS N/A
- CMRX 2013
- Fundamental
- Price
- GNSS $3.75
- CMRX $0.93
- Analyst Decision
- GNSS Strong Buy
- CMRX Strong Buy
- Analyst Count
- GNSS 3
- CMRX 1
- Target Price
- GNSS $5.08
- CMRX $11.00
- AVG Volume (30 Days)
- GNSS 106.7K
- CMRX 119.4K
- Earning Date
- GNSS 12-05-2024
- CMRX 11-08-2024
- Dividend Yield
- GNSS N/A
- CMRX N/A
- EPS Growth
- GNSS N/A
- CMRX N/A
- EPS
- GNSS N/A
- CMRX N/A
- Revenue
- GNSS $27,968,000.00
- CMRX $144,000.00
- Revenue This Year
- GNSS N/A
- CMRX $3,040.12
- Revenue Next Year
- GNSS $138.10
- CMRX N/A
- P/E Ratio
- GNSS N/A
- CMRX N/A
- Revenue Growth
- GNSS N/A
- CMRX N/A
- 52 Week Low
- GNSS $1.51
- CMRX $0.75
- 52 Week High
- GNSS $4.04
- CMRX $1.30
- Technical
- Relative Strength Index (RSI)
- GNSS 60.29
- CMRX 60.78
- Support Level
- GNSS $3.67
- CMRX $0.80
- Resistance Level
- GNSS $3.94
- CMRX $0.98
- Average True Range (ATR)
- GNSS 0.14
- CMRX 0.05
- MACD
- GNSS -0.02
- CMRX 0.01
- Stochastic Oscillator
- GNSS 77.78
- CMRX 83.33
About GNSS Genasys Inc.
Genasys Inc is a provider of critical communications solutions designed to help keep people safe. The company is engaged in the design, development, and commercialization of directed and multidirectional sound technologies, voice broadcast products and location-based mass messaging solutions for emergency warning and workforce management. Its operating segment includes Hardware and Software. The company generates maximum revenue from the Hardware segment. Geographically, it derives a majority of revenue from the Americas region and also has its presence in the Asia Pacific and Europe, Middle East and Africa.
About CMRX Chimerix Inc.
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.